喵ID:wuLFZW免责声明

Trichosanatine alleviates oxidized low-density lipoprotein induced endothelial cells injury via inhibiting the LOX-1/p38 MAPK pathway

天花粉碱通过抑制 LOX-1/p38 MAPK 通路减轻氧化低密度脂蛋白诱导的内皮细胞损伤

基本信息

DOI:
--
发表时间:
2016
期刊:
Am J Transl Res
影响因子:
--
通讯作者:
Sai-Bo Chen(程赛博)
中科院分区:
其他
文献类型:
--
作者: Lei Zhang (张蕾);Yu-Hua Jia (贾钰华);Xiao-Shan Zhao (赵晓山);Feng-Hua Zhou (周凤华);Yun-Yun Pan (潘芸芸);Qiang Wan (万强);Xiao-Bing Cui (崔小冰);Xue-Gang Sun (孙学刚);Yu-Yao Chen (陈育尧);Yu Zhang (张宇);Sai-Bo Chen(程赛博)研究方向: -- MeSH主题词: --
关键词: --
来源链接:pubmed详情页地址

文献摘要

The LOX-1/p38 mitogen-activated protein kinase (MAPK) pathway has been proved to participate in the endothelial dysfunction in atherosclerosis. Trichosanatineis is an active compound isolated from the peel of Trichosanthes kirilowii. This study aims to determine whether trichosanatine prevents the oxidized low-density lipoprotein (ox-LDL)-induced insult through inhibition of the LOX-1/p38 MAPK pathway in HUVECs. HUVECs were treated with 150 mg/ml ox-LDL for 24 h to establish an ox-LDL-induced endothelial injury model. Cell viability, mitochondrial membrane potential (MMP), apoptosis, reactive oxygen species (ROS) level, LOX-1 and p38 MAPK expression level were measured. The results indicated that HUVECs were pretreated with either 100 mM trichosanatine or LOX-1 shRNA prior to exposure to ox-LDL for 24 h. Exposure of HUVECs to 150 mg/ml ox-LDL for 24 h significantly up-regulated the expression levels of LOX-1. The increased expression levels of LOX-1 were markedly attenuated by pretreatment with 100 mM trichosanatine. In addition, the ox-LDL-induced increase in phosphorylated (p) p38 MAPK expression was ameliorated by pretreatment with LOX-1 shRNA. Pretreatment of HUVECs with either trichosanatine or LOX-1 shRNA before exposure to ox-LDL significantly inhibited the ox-LDL-induced injuries, as evidenced by an increase in cell viability, a decrease in apoptotic cells, a ROS generation and a loss of MMP. In conclusion, we have demonstrated for the first time that the LOX-1/p38 MAPK pathway contributes to the ox-LDL-induced injury in HUVECs. Meanwhile, the trichosanatine protects the HUVECs against ox-LDL-induced injury at least in part by inhibiting the activated of LOX-1/p38 MAPK pathway.
LOX - 1 / p38丝裂原活化蛋白激酶(MAPK)通路已被证实参与动脉粥样硬化中的内皮功能障碍。天花粉蛋白是从栝楼皮中分离出的一种活性化合物。本研究旨在确定天花粉蛋白是否通过抑制人脐静脉内皮细胞(HUVECs)中的LOX - 1 / p38 MAPK通路来预防氧化低密度脂蛋白(ox - LDL)诱导的损伤。用150μg/ml ox - LDL处理HUVECs 24小时以建立ox - LDL诱导的内皮损伤模型。测量细胞活力、线粒体膜电位(MMP)、细胞凋亡、活性氧(ROS)水平、LOX - 1和p38 MAPK表达水平。结果表明,在暴露于ox - LDL 24小时之前,HUVECs用100μM天花粉蛋白或LOX - 1 shRNA进行预处理。HUVECs暴露于150μg/ml ox - LDL 24小时显著上调了LOX - 1的表达水平。用100μM天花粉蛋白预处理可显著减弱LOX - 1表达水平的升高。此外,用LOX - 1 shRNA预处理可改善ox - LDL诱导的磷酸化(p)p38 MAPK表达的增加。在暴露于ox - LDL之前,用天花粉蛋白或LOX - 1 shRNA预处理HUVECs可显著抑制ox - LDL诱导的损伤,表现为细胞活力增加、凋亡细胞减少、ROS产生减少以及MMP损失减少。总之,我们首次证明了LOX - 1 / p38 MAPK通路有助于HUVECs中ox - LDL诱导的损伤。同时,天花粉蛋白至少部分通过抑制LOX - 1 / p38 MAPK通路的激活来保护HUVECs免受ox - LDL诱导的损伤。
参考文献(0)
被引文献(0)

数据更新时间:{{ references.updateTime }}

关联基金

基于ACE2-Ang(1-7)-Mas轴探讨定心方对动脉粥样硬化易损斑块稳定性的干预机制
批准号:
81373574
批准年份:
2013
资助金额:
65.0
项目类别:
面上项目
Sai-Bo Chen(程赛博)
通讯地址:
--
所属机构:
--
电子邮件地址:
--
免责声明免责声明
1、猫眼课题宝专注于为科研工作者提供省时、高效的文献资源检索和预览服务;
2、网站中的文献信息均来自公开、合规、透明的互联网文献查询网站,可以通过页面中的“来源链接”跳转数据网站。
3、在猫眼课题宝点击“求助全文”按钮,发布文献应助需求时求助者需要支付50喵币作为应助成功后的答谢给应助者,发送到用助者账户中。若文献求助失败支付的50喵币将退还至求助者账户中。所支付的喵币仅作为答谢,而不是作为文献的“购买”费用,平台也不从中收取任何费用,
4、特别提醒用户通过求助获得的文献原文仅用户个人学习使用,不得用于商业用途,否则一切风险由用户本人承担;
5、本平台尊重知识产权,如果权利所有者认为平台内容侵犯了其合法权益,可以通过本平台提供的版权投诉渠道提出投诉。一经核实,我们将立即采取措施删除/下架/断链等措施。
我已知晓